Total Utang marang Modal CG Oncology Corp (CGON)

CG Oncology - logo grafis emiten CGON

CG Oncology, Inc. (CGON) develops methods to combat bladder cancer, focusing on patient medical needs regardless of market cycles. The company is implementing sustainable biomaterial logistics and automating laboratory reports via digital algorithms. The stock price trend on GURU.Markets confirms this data, while the individual debt-to-equity ratio stands at 0.01.

cgoncology.com (CGON): Rasio Utang marang Ekuitas saka 21.02.2024 nganti 01.11.2026

Rincian metrik lan analitis perusahaan CG Oncology Therapeutics (CGON)

- rega saham lan konsensus proyeksi valuasi:
Rega saham CG Oncology|CGON - Target konsensus
- rincian kapitalisasi pasar:
Kapitalisasi pasar CG Oncology|CGON - Nilai Perusahaan
- indikator kapitalisasi buku:
Aset Bersih saben Siji Saham CG Oncology|CGON - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku cgoncology.com|CGON - Gunggung Aset Perusahaan
- rincian utang lan likuiditas:
Total Utang marang Modal CG Oncology, Inc.|CGON - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas CG Oncology, Inc.|CGON - Kewajiban utang agregat|Utang marang nilai buku CG Oncology|CGON - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan CG Oncology|Indikator likuiditas cepet cgoncology.com
- data bathi resik lan rasio valuasi:
CGON - Bathi resik
Pambiji fundamental perusahaan:CG Oncology
Produk dadi CG Oncology, Inc.

To filter out the issuer's debt risks, it is critical to assess the balance between borrowed funds and equity reserves. By analyzing the financing structure chart (debt-to-equity), an investor can see the proportion of total debt to equity, which determines the degree of financial autonomy of CG Oncology, Inc. (CGON) when upgrading certified facilities and producing drugs for clinical trials.

Analisis pesaing CG Oncology, Inc.

ONC (BeiGene) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Halozyme Therapeutics, Inc. (HALO)|Total Utang marang Modal RVMD|Total Utang marang Modal Ascentage Pharma Corp (AAPG)|Utang marang Ekuitas UroGen Pharma Ltd. URGN|BCAX: Rasio Utang marang Ekuitas|Personalis - Total Utang marang Modal|Erasca Inc (ERAS) - Rasio Total Utang marang Ekuitas|DCTH: Total Utang marang Modal|Utang marang Modal Y-mAbs Corp (YMAB)|Utang marang Ekuitas Aura Biosciences, Inc.|CADL: Rasio Kabeh Utang marang Dana Pribadi|Rasio Total Utang marang Ekuitas ARAY (Accuray)|SLS (sellaslifesciences.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ACTU (Actuate Therapeutics, Inc)|CTOR - Rasio Total Utang marang Ekuitas|HURA: Rasio Total Utang marang Ekuitas|TARA - Total Utang marang Modal|Fate Therapeutics (FATE) - Utang marang Ekuitas|Aadi Bioscience - Rasio Kabeh Utang marang Dana Pribadi|TCRX (TScan Therapeutics Inc) - Total Utang marang Modal|Utang marang Modal Champions Oncology Corp CSBR|Total Utang marang Modal XBIT|Rasio Total Utang marang Ekuitas cel-sci.com CVM|Total Utang marang Modal OSTX (OS Therapies)|Rasio Utang marang Modal radiopharmtheranostics.com|ARTV: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ANL (Adlai Nortye Ltd.)|Veru Inc. (VERU) - Utang marang Ekuitas|Utang marang Modal tempesttx.com (TPST)|Utang marang Ekuitas Xilio Therapeutics Inc|Rasio Utang marang Ekuitas RENB (Enochian BioSciences)|Total Utang marang Modal MURA|Rasio Total Utang marang Ekuitas kairospharma.com KAPA|Utang marang Ekuitas OnKure Therapeutics OKUR|CytoMed Therapeutics Ltd (GDTC) - Utang marang Modal|CRIS - Utang marang Ekuitas|APLM: Utang marang Ekuitas|Tharimmune Corp (THAR) - Utang marang Ekuitas|Utang marang Modal Advanced Biomed (ADVB)|GNPX (Genprex, Inc.) - Total Utang marang Modal|CLDI - Rasio Utang marang Modal|Rasio Total Utang marang Ekuitas SBFM (Sunshine Biopharma, Inc.)|XBIO - Utang marang Modal|Salarius - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi PPBT|AON - Total Utang marang Modal|Koefisien Total Utang marang Modal beigene.com BGNE|Checkpoint Therapeutics, Inc. (CKPT) - Utang marang Ekuitas|Rasio Utang marang Ekuitas ELEV|ICAD (iCAD Inc.) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Ikena (IKNA)|Rasio Total Utang marang Ekuitas NTBL (Notable Labs, Ltd.)|Koefisien Total Utang marang Modal viracta.com|Total Utang marang Modal MOR (MorphoSys)|NAYA - Rasio Total Utang marang Ekuitas|Ascentage Pharma Group Ltd - Total Utang marang Modal